Pharmaceuticals

Plasma Protein Therapeutics Market Report 2026: Strategic Insights and Revenue Outlook

February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the plasma protein therapeutics market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Plasma Protein Therapeutics Market expected to grow between 2026 and 2030?

The plasma protein therapeutics market has demonstrated substantial growth in recent years. Its valuation is projected to increase from $34.68 billion in 2025 to $37.09 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.9%. This expansion over the historic period is largely attributable to the increasing prevalence of primary immunodeficiency disorder, the rising demand for immunoglobulin therapies, the limited plasma donation infrastructure, advancements in protein purification technologies, and regulatory approvals for plasma-derived therapies.

The plasma protein therapeutics market is projected to experience substantial expansion in the coming years, reaching $48.98 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecast period is driven by factors such as the rise in recombinant albumin and coagulation factor production, the broader adoption of subcutaneous administration techniques, escalating healthcare spending in developing economies, innovations in precision medicine, and increased partnerships between public and private entities for plasma collection. Key developments expected over the forecast horizon encompass the creation of personalized plasma protein therapies, an increase in recombinant protein manufacturing, wider acceptance of subcutaneous administration, a heightened understanding of rare blood conditions, and improvements in supply chain and cold chain management.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9213&type=smp

Which Drivers Are Influencing Market Acceleration In The Plasma Protein Therapeutics Market?

The expanding occurrence of autoimmune conditions is projected to drive the expansion of the plasma protein therapeutics market in the future. Such a disorder arises when the body’s immune system mistakenly targets and damages its own healthy cells. Therapeutic plasma exchange serves as a treatment for autoimmune diseases, which develop when the body incorrectly perceives its own components as foreign and generates proteins, termed autoantibodies, that subsequently assault those misidentified body parts. For example, research performed by the University of Glasgow, a public university located in the UK, published in May 2023 and involving 22 million individuals, revealed that roughly 10% of the UK’s population is affected by autoimmune disorders, a figure higher than prior estimations from 2022. Consequently, the rising occurrence of autoimmune conditions is fueling the expansion of the plasma protein therapeutics market moving ahead.

What Segments Are Identified Within The Structure Of The Plasma Protein Therapeutics Market?

The plasma protein therapeutics market covered in this report is segmented –

1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products

2) By Route Of Administration: Intravenous, Subcutaneous

3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications

Subsegments:

1) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Albumin: Human Serum Albumin, Recombinant Albumin

3) By Coagulation Factor: Factor VIII, Factor IX, Prothrombin Complex Concentrates

4) By C1-Esterase Inhibitors: Human C1-Esterase Inhibitors, Recombinant C1-Esterase Inhibitors

5) By Other Products: Fibrinogen, Alpha-1 Antitrypsin, Clotting Factor Concentrates

Which Trends Are Influencing The Development Of The Plasma Protein Therapeutics Market?

Leading companies operating within the plasma protein therapeutics market are concentrating on developing novel solutions, such as lyophilized plasma formulations, to satisfy the growing requirement for blood products that are portable, stable, and quick to use in emergency and pre-hospital care environments. Lyophilized plasma products are freeze-dried preparations that offer an extended shelf life, simplified storage, and faster reconstitution compared to traditional frozen plasma, rendering them highly appropriate for trauma, emergency medicine, and field settings. For instance, in October 2023, Octapharma AG, a pharmaceutical company based in Switzerland, obtained approval from European medical authorities for the lyophilized version of its octaplasLG product. This sophisticated formulation allows for convenient pre-hospital transfusion, providing rapid accessibility, straightforward handling, and improved stability for critical care situations. The product aids in the effective management of trauma and bleeding emergencies, demonstrating Octapharma’s commitment to advancing patient care through innovative plasma-based therapies.

Which Key Players Are Driving Competition In The Plasma Protein Therapeutics Market?

Major companies operating in the plasma protein therapeutics market are CSL Behring LLC, Grifols SA, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion SpA, LFB SA, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions BV, Bio Products Laboratory Ltd., Biotest AG, Taibang Biological Group Co Ltd, Octapharma Plasma Inc., Green Cross Corporation, China National Biotec Group Company Limited, Kamada Ltd., Shire PLC, Octapharma AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Which Region Is Projected To Lead The Plasma Protein Therapeutics Market During The Forecast Period?

North America was the largest region in the plasma protein therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma protein therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Plasma Protein Therapeutics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9213&type=smp

Browse Through More Reports Similar to the Global Plasma Protein Therapeutics Market 2026, By The Business Research Company

Plasma Protein Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Therapeutic Plasma Exchange Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Peptide Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795